Reply to the Editor  by Bobadilla, J.L. et al.
The initial experiment with the Shel-
high valve in a self-expandable conduit
was performed in sheep by us and the re-
sults published as a book chapter in Trans-
catheter Valve Repair by Hijazi, Bonhoef-
fer, Feldman, and Ruiz.5 In this animal
experiment, the Shelhigh valve that had
been placed in the self-expanding Cook Z
stent (Cook Inc, Bloomington, Ind) was
placed with the help of a delivery gun into
the right ventricular outflow tract of sheep.
The approach was perventricular and no
cardiopulmonary bypass was used. The
clinical application of this approach fol-
lowed this animal experiment.
I was astonished that none of our animal
work with the Shelhigh valve or the per-
ventricular approach was acknowledged by
Berdat and coworkers in the case report.
Zahid Amin, MD
University of Nebraska/Creighton University
Joint Division of Pediatric Cardiology
Omaha, NE
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Reply to the Editor:
We greatly welcome the valuable com-
ments from our colleague Dr Amin and his
important contribution to the development
of this technique.1 Due to space restrictions
for published articles, we could not go into
details regarding the development and his-
torical background of this new device. We
therefore greatly appreciate that this infor-
mation is still presented to the readership.
We would like to emphasize, however, that
our group was the first to clinically implant
the Shelhigh injectable pulmonary valve,
although Schreiber and colleagues2 were
the first to publish their experience.
Pascal A. Berdat, MD
Thierry P. Carrel, MD
Swiss Cardiovascular Center Bern
Clinic for Cardiovascular Surgery
University Hospital
Bern, Switzerland
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Inflow occlusion in the era of
modern cardiac surgery
To the Editor:
We read with interest the article titled “In-
flow Occlusion Pulmonary Embolectomy
in the Modern Era of Cardiac Surgery” by
Bobadilla and associates.1 The following
points are not clear from the contents of the
article.
First, how was the core temperature
lowered? Was it lowered with a cooling
blanket or just by dropping the temperature
of the operating theater, and how long did
it take for the temperature to drop to 32°C?
Second, for what duration was the in-
flow occluded?
Absence of structural or functional dam-
age to the brain has been noted during
circulatory arrest. Probability of safe circu-
latory arrest according to degree of hypo-
thermia is shown in Table 1.
There are a number of situations wherein
familiarity with inflow occlusion technique
may be of use, such as pulmonary valvot-
omy, aortic valvotomy, and atrial septec-
tomy. Patients who have pulmonary atresia
with intact septum can undergo relief of
right ventricular outflow tract obstruction
with a patch, pulmonary valvotomy, or a
Brock procedure. Other procedures that
have been performed safely by this tech-
nique are tricuspid valvectomy, emergency
perforation of a ventricular septal patch,
obtaining full thickness myocardial biopsy,
and repair of penetrating wounds of the
heart.2
Undoubtedly, this technique represents
a considerable cost savings over the same
procedures performed with cardiopulmo-
nary bypass. In the current economic era of
limited health care budget, any surgical
technique that provides equivalent results
is to be preferred over more expensive al-
ternatives.
Jaswinder Singh, MCh
Rajinder S. Dhaliwal, MCh
Suvakanta Biswal, MS
Naveen Swami, MS
Department of Cardiovascular
& Thoracic Surgery
Postgraduate Institute of
Medical Education & Research
Chandigarh, India
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Reply to the Editor:
We graciously thank the authors of this
letter to the editor for supplying further
TABLE 1. Probability of safe circula-
tory arrest according to hyperthermia
Temperature (°C)
Duration of safe
circulatory arrest (min)
37 3
28 10
18 45-60
Revised from Kouchoukos NT, Blackstone EH,
Doty DB, Hanley FL, Karp RB. Hypothermia, cir-
culatory arrest and cardiopulmonary bypass. In:
Kirklin/Barratt-Boyes Cardiac Surgery, 3rd ed.
Philadelphia: Churchill Livingstone; 2003. p. 80
(Table 2.9A). Reprinted with permission from
Elsevier, Inc.
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supporting data that could not be included
in the original manuscript because of space
limitations. To briefly clarify the two
points of interests raised by this letter, a
brief episode of occlusion of less than 5
minutes was used in extraction of the em-
bolism and repair of the pulmonary arteri-
otomy. The method of patient cooling was
both active (cooling blanket) and passive,
through operating theater temperature and
radiation losses during line placement and
anesthetic induction. As is illustrated by
the table supplied by Singh and associates,
core temperatures from 28°C to 37°C allow
occlusion times of 3 to 10 minutes. We
appreciate the additional indications for the
use of inflow occlusion, and we fully agree
with this list, as our senior author is an
experienced pediatric cardiac surgeon and
intimately familiar with these procedures.
In conclusion, we agree that inflow occlu-
sion continues to have a select place in the
armamentarium of today’s cardiac surgeon
and that its clinical results, not withstand-
ing any economic benefits, reserve it a con-
tinued place in the modern era of cardiac
surgery.
J. L. Bobadilla, MD
C. H. Wigfield, MD
P. S. Chopra, MD
Department of Cardiothoracic Surgery
University of Wisconsin Hospital and Clinics
Madison, WI
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